$Recro Pharma, Inc.(REPH)$ 8-K - Current report Filed: 2018-08-07 AccNo: 0001193125-18-240338 Size: 741 KBItem 2.02: Results of Operations and Financial ConditionItem 8.01: Other EventsItem 9.01: Financial Statements and Exhibits 网页链接